🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John S. Bomalaski

Polaris (United States)

ORCID: 0000-0002-9454-7271

Also affiliated with Polaris Group (United States), Plex Pharmaceuticals (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies”.

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies

British Journal of Cancer(2021)10.1038/s41416-020-01230-8
N/A
0DataRank · unranked
43 citations

Filip Jankú, Vivek Subbiah, John Stewart, Sapna P. Patel, Ahmed O. Kaseb +10 more

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11508
N/A
0DataRank · unranked
9 citations

Angela C. Hirbe, Jingqin Luo, Peter John Oppelt, Mia C. Weiss, Vanessa Eulo +14 more

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100498
N/A
0DataRank · unranked
19 citations

Cassandra B. Higgins, Brian Andrew Van Tine, John S. Bomalaski, Brian J. DeBosch, Yiming Zhang

Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2642
N/A
0DataRank · unranked
14 citations

Jeff C. Kremer, Caitlyn B. Brashears, Zongtao Lin, Zhixian Hu, Alliny C.S. Bastos +12 more

Data from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

(2023)10.1158/1078-0432.c.6736752
N/A
0DataRank · unranked
0 citations

Jeff C. Kremer, Caitlyn B. Brashears, Zongtao Lin, Zhixian Hu, Alliny C.S. Bastos +12 more

Arginine deprivation/citrulline augmentation with ADI-PEG20 as novel therapy for complications in type 2 diabetes

Molecular Metabolism(2024)10.1016/j.molmet.2024.102020
N/A
0DataRank · unranked
5 citations

Porsche Sandow, Jing Wang, Zhimin Xu, Modesto Rojas, John S. Bomalaski +4 more

BCL-XL Protects ASS1-Deficient Cancers from Arginine Starvation–Induced Apoptosis

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2548
N/A
0DataRank · unranked
4 citations

Ana Carolina Paschoalini Mafra, Alliny C.S. Bastos, Li Cao, Maria Serra Bonet, Caitlyn B. Brashears +9 more